One of the first pieces of evidence that fed the hypothesis associating JNK3 and AD was described 15 years ago [83] when it was demonstrated that the expression of JNK3 is co-located with ALZ-50 antigen in brains in AD hippocampal sections. This evidence concerns the gene MAPK10 and Alzheimer disease.